Protocol No
PULM-ACCELERON-ZENITH
Phase
III
Summary
This project is being done to determine the efficacy and effect of sotatercept on patients with PAH through a series of clinical test and questionnaires.
Description
Sotatercept in Participants With Pulmonary Arterial Hypertension WHO FC III or FC IV at High Risk of Mortality
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov